BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

704 related articles for article (PubMed ID: 12874233)

  • 1. Alternate class I MHC antigen processing is inhibited by Toll-like receptor signaling pathogen-associated molecular patterns: Mycobacterium tuberculosis 19-kDa lipoprotein, CpG DNA, and lipopolysaccharide.
    Tobian AA; Potter NS; Ramachandra L; Pai RK; Convery M; Boom WH; Harding CV
    J Immunol; 2003 Aug; 171(3):1413-22. PubMed ID: 12874233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis.
    Noss EH; Pai RK; Sellati TJ; Radolf JD; Belisle J; Golenbock DT; Boom WH; Harding CV
    J Immunol; 2001 Jul; 167(2):910-8. PubMed ID: 11441098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of IFN-gamma-induced class II transactivator expression by a 19-kDa lipoprotein from Mycobacterium tuberculosis: a potential mechanism for immune evasion.
    Pai RK; Convery M; Hamilton TA; Boom WH; Harding CV
    J Immunol; 2003 Jul; 171(1):175-84. PubMed ID: 12816996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant Lipoprotein Rv1016c Derived from
    Su H; Zhu S; Zhu L; Huang W; Wang H; Zhang Z; Xu Y
    Front Cell Infect Microbiol; 2016; 6():147. PubMed ID: 27917375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged toll-like receptor signaling by Mycobacterium tuberculosis and its 19-kilodalton lipoprotein inhibits gamma interferon-induced regulation of selected genes in macrophages.
    Pai RK; Pennini ME; Tobian AA; Canaday DH; Boom WH; Harding CV
    Infect Immun; 2004 Nov; 72(11):6603-14. PubMed ID: 15501793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A subset of Toll-like receptor ligands induces cross-presentation by bone marrow-derived dendritic cells.
    Datta SK; Redecke V; Prilliman KR; Takabayashi K; Corr M; Tallant T; DiDonato J; Dziarski R; Akira S; Schoenberger SP; Raz E
    J Immunol; 2003 Apr; 170(8):4102-10. PubMed ID: 12682240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycobacterium tuberculosis inhibits macrophage responses to IFN-gamma through myeloid differentiation factor 88-dependent and -independent mechanisms.
    Fortune SM; Solache A; Jaeger A; Hill PJ; Belisle JT; Bloom BR; Rubin EJ; Ernst JD
    J Immunol; 2004 May; 172(10):6272-80. PubMed ID: 15128816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Processing of Mycobacterium tuberculosis antigen 85B involves intraphagosomal formation of peptide-major histocompatibility complex II complexes and is inhibited by live bacilli that decrease phagosome maturation.
    Ramachandra L; Noss E; Boom WH; Harding CV
    J Exp Med; 2001 Nov; 194(10):1421-32. PubMed ID: 11714749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial heat shock proteins promote CD91-dependent class I MHC cross-presentation of chaperoned peptide to CD8+ T cells by cytosolic mechanisms in dendritic cells versus vacuolar mechanisms in macrophages.
    Tobian AA; Canaday DH; Boom WH; Harding CV
    J Immunol; 2004 May; 172(9):5277-86. PubMed ID: 15100266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycobacterium tuberculosis LprG (Rv1411c): a novel TLR-2 ligand that inhibits human macrophage class II MHC antigen processing.
    Gehring AJ; Dobos KM; Belisle JT; Harding CV; Boom WH
    J Immunol; 2004 Aug; 173(4):2660-8. PubMed ID: 15294983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits gamma interferon-regulated HLA-DR and Fc gamma R1 on human macrophages through Toll-like receptor 2.
    Gehring AJ; Rojas RE; Canaday DH; Lakey DL; Harding CV; Boom WH
    Infect Immun; 2003 Aug; 71(8):4487-97. PubMed ID: 12874328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of IL-10 receptor function in alveolar macrophages by Toll-like receptor agonists.
    Fernandez S; Jose P; Avdiushko MG; Kaplan AM; Cohen DA
    J Immunol; 2004 Feb; 172(4):2613-20. PubMed ID: 14764735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CpG oligodeoxynucleotides down-regulate macrophage class II MHC antigen processing.
    Chu RS; Askew D; Noss EH; Tobian A; Krieg AM; Harding CV
    J Immunol; 1999 Aug; 163(3):1188-94. PubMed ID: 10415013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cells induce extended class II MHC compartments in dendritic cells in a Toll-like receptor-dependent manner.
    Boes M; Bertho N; Cerny J; Op den Brouw M; Kirchhausen T; Ploegh H
    J Immunol; 2003 Oct; 171(8):4081-8. PubMed ID: 14530329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptor 4 and Toll-IL-1 receptor domain-containing adapter protein (TIRAP)/myeloid differentiation protein 88 adapter-like (Mal) contribute to maximal IL-6 expression in macrophages.
    Schilling D; Thomas K; Nixdorff K; Vogel SN; Fenton MJ
    J Immunol; 2002 Nov; 169(10):5874-80. PubMed ID: 12421970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of many immunologically important genes in Mycobacterium tuberculosis-infected macrophages is independent of both TLR2 and TLR4 but dependent on IFN-alphabeta receptor and STAT1.
    Shi S; Blumenthal A; Hickey CM; Gandotra S; Levy D; Ehrt S
    J Immunol; 2005 Sep; 175(5):3318-28. PubMed ID: 16116224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptor protein-3 in dendritic cells facilitates phagosomal toll-like receptor signaling and antigen presentation to CD4(+) T cells.
    Mantegazza AR; Guttentag SH; El-Benna J; Sasai M; Iwasaki A; Shen H; Laufer TM; Marks MS
    Immunity; 2012 May; 36(5):782-94. PubMed ID: 22560444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycobacterium tuberculosis inhibits MHC class II antigen processing in murine bone marrow macrophages.
    Noss EH; Harding CV; Boom WH
    Cell Immunol; 2000 Apr; 201(1):63-74. PubMed ID: 10805975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secreted proteins from Mycobacterium tuberculosis gain access to the cytosolic MHC class-I antigen-processing pathway.
    Lewinsohn DM; Grotzke JE; Heinzel AS; Zhu L; Ovendale PJ; Johnson M; Alderson MR
    J Immunol; 2006 Jul; 177(1):437-42. PubMed ID: 16785540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor ligands directly promote activated CD4+ T cell survival.
    Gelman AE; Zhang J; Choi Y; Turka LA
    J Immunol; 2004 May; 172(10):6065-73. PubMed ID: 15128790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.